The Consortium of Adolescent and Young Adult Cancer Centers (CAYACC) is a working group of AYA oncologists from comprehensive cancer centers including:
The consortium was founded in 2015 to collaboratively help accelerate progress, understanding and improvements in the field of adolescent and young adult cancer.
Data and insights gained from CAYACC's National AYA Cancer Patient and Survivor Survey will inform follow-up studies and the creation of additional nationwide partnerships.
The study is approved by the Internal review Board at Roswell Park Cancer Institute, the center that will coordinate the data collection. It is funded by a grant from Hyundai Hope On Wheels, a 501(c)(3) nonprofit organization. Primary funding for Hyundai Hope On Wheels comes from Hyundai Motor America and its more than 800 U.S. dealers.
Dr. Lynda Kwon Beaupin is a pediatric hematologist-oncologist in Buffalo, New York and is affiliated with Roswell Park Cancer Institute and Women and Children's Hospital of Buffalo. She received her medical degree from Saba University School of Medicine, Saba, Netherland-Antilles.
Her research interests include adolescent and young adult oncology and survivorship, oncofertility (fertility issues among cancer patients) and survivorship.
Dr. Beaupin worked with the Centers for Disease Control (CDC) in 2012 to examine the barriers that limit adolescents with cancer from enrolling in clinical trials. In 2013, she was a member of the National Cancer Policy Forum of AYA Oncology, led by the Institute of Medicine Planning. She is currently a member of the National Comprehensive Cancer Network's (NCCN) AYA Guidelines Panel.
Dr. Beaupin was chairperson of the 2015 Critical Mass Young Adult Alliance Annual Conference, which took place in Chicago, Illinois.
Dr. Scott Borinstein received a combined MD, PhD degree at the Medical College of Virginia. He completed his pediatric residency and pediatric hematology/oncology fellowship training at Seattle Children's Hospital and the Fred Hutchinson Cancer Center.
Dr. Borinstein has been the director of the pediatric sarcoma and adolescent and young adult cancer programs at Vanderbilt University since 2009. His passion is improving the care of teenagers and young adults with cancer. He has served as pediatric hematology/oncology fellowship program director since 2013.
Dr. Borinstein's clinical and research efforts focus on the treatment of bone and soft tissue sarcomas and AYA oncology. He has extensive experience in basic science and clinical investigation and is an active member of the Children's Oncology Group and the Connective Tissue Oncology Society.
Dr. Damon Reed is a Pediatric Oncologist at Moffitt Cancer Center and Johns Hopkins / All Children’s Hospital. He is the leader of the Adolescent and Young Adult Program at Moffitt, and an Associate Professor of Oncologic Sciences at the University of South Florida.
Dr. Reed is also the leader of the National Pediatric Cancer Foundation's Sunshine Project. His interests include improving the care and outcomes of children and young adults with sarcoma, pediatric early phase trials, and addressing the needs of adolescent and young adult (AYA) oncology patients through research and program building.
Dr. Peter Shaw is the Deputy Director of the Johns Hopkins All Children’s Cancer & Blood Disorders Institute and Associate Professor of Oncology (PAR) at the Johns Hopkins University School of Medicine.
Prior to his August 2016 appointment, he served as Clinical Director of Oncology at Children's Hospital of Pittsburgh, part of UPMC— where he started the Adolescent and Young Adult (AYA) program in 2006.
Dr. Shaw was a founding member of the Fertility Preservation Group working with specialists at Magee Women's Hospital of UPMC in 2007. He is the principal investigator of an IRB study of ovarian tissue cryopreservation and the co-investigator of a testicular tissue cryopreservation study.
He has published more than five peer-reviewed articles on AYA oncology to date, including an article detailing the first documented improvement in clinical trial enrollment numbers as a result of collaborative patient treatment by both pediatric and medical oncologists.
Dr. Shaw received his medical degree from Albert Einstein College of Medicine of Yeshiva University. He completed his residency at Montefiore Medical Center, Bronx, N.Y., and a fellowship at Children's Memorial Hospital (Northwestern University), Chicago.
Dr. Nicholas "Nick" Yeager is a pediatric oncologist and director of the Adolescent and Young Adult Oncology program at Nationwide Children's Hospital in Columbus, Ohio. He is an Assistant Professor of Pediatrics at The Ohio State University College of Medicine.
Dr. Yeager has been a member of Critical Mass (previously the Livestrong Young Adult Alliance) since 2008.
In addition to his work in AYA, Nick is an associate program director of the Hitchcock-Wilson Fellowship in pediatric oncology and has a clinical interest in sarcoma.
A graduate of Youngstown State University and Northeastern Ohio Medical University, he completed his pediatric and hematology/oncology training at Nationwide Children's Hospital, and has been on faculty since 2003. Nick is also a 20-year survivor of testicular cancer.